Your browser doesn't support javascript.
loading
The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.
Arinaminpathy, Nimalan; Gomez, Gabriela B; Sachdeva, Kuldeep S; Rao, Raghuram; Parmar, Malik; Nair, Sreenivas A; Rade, Kiran; Kumta, Sameer; Hermann, David; Hanson, Christy; Chin, Daniel P; Dewan, Puneet.
Afiliação
  • Arinaminpathy N; MRC Centre for Global Infectious Disease Analysis, Faculty of Medicine, Imperial College London, United Kingdom.
  • Gomez GB; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Sachdeva KS; Central TB Division, Government of India, New Delhi, India.
  • Rao R; Central TB Division, Government of India, New Delhi, India.
  • Parmar M; India Country Office, World Health Organization, New Delhi, India.
  • Nair SA; Stop TB Partnership, Geneva, Switzerland.
  • Rade K; India Country Office, World Health Organization, New Delhi, India.
  • Kumta S; Bill and Melinda Gates Foundation, India Country Office, New Delhi, India.
  • Hermann D; Bill and Melinda Gates Foundation, Seattle, WA, United States of America.
  • Hanson C; Bill and Melinda Gates Foundation, Seattle, WA, United States of America.
  • Chin DP; Bill and Melinda Gates Foundation, Seattle, WA, United States of America.
  • Dewan P; Global Good, Intellectual Ventures, Seattle, WA, United States of America.
PLoS One ; 15(3): e0230808, 2020.
Article em En | MEDLINE | ID: mdl-32218585

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article